A basal analogue highly effective even in patients after kidney transplantation
Authors:
Miroslav Paľko
Authors‘ workplace:
I. interná klinika LF UPJŠ a UNLP Košice
Published in:
Diab Obez 2020; 20(40): 112-113
Category:
Case studies
Labels
Diabetology ObesitologyArticle was published in
Diabetes and obesity
2020 Issue 40
-
All articles in this issue
- Editoriál
- Spomienka na Borisa Krahulca
- Clinical data on the use of insulin glargine 300 U/ml in adult and paediatric populations with type 1 diabetes and their meta-analysis
- Metformin treatment is still under discussion
- GDF15: a new predictive biomarker for type 2 diabetes mellitus in clinical practice
- Impaired awareness of hypoglycaemia: management and experience from Sheffield
- Presence of alcohol in the breath of a diabetic patient – a possible forensic problem
- Does diabetes support cancer development?
- Remission of nocturnal hypoglycemia after a change in basal insulin
- Biosimilar insulin glargine added to treatment with oral antidiabetics
- A basal analogue highly effective even in patients after kidney transplantation
- Study EMPEROR-Reduced: design, results and implications for clinical practice
- Do we need „cardio-metabolic“ specialists?
- 80. virtuálna konferencia American Diabetes Association
- Rozšírenie technológií do diabetologickej praxe
- Jubilejné XXX. diabetologické dni s medzinárodnou účasťou
- Diabetes and obesity
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Presence of alcohol in the breath of a diabetic patient – a possible forensic problem
- Metformin treatment is still under discussion
- Impaired awareness of hypoglycaemia: management and experience from Sheffield
- GDF15: a new predictive biomarker for type 2 diabetes mellitus in clinical practice